Our goal is to find novel disease mechanisms and molecular targets, that can be used for innovative therapies for inflammatory skin diseases and cutaneous T cell lymphoma.

Our aim in the group is to uncover novel molecular mechanisms that
regulate inflammation and innate immune responses.

Our aim is to characterize and understand novel pathways and molecules in T cell activation and differentiation in inflammatory skin diseases.